Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 25
- Registration Number
- NCT05679583
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 116
- Registration Number
- NCT05679921
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease
Recruiting
- Conditions
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 10
- Registration Number
- NCT05679076
- Locations
- 🇰🇷
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Safety and Efficacy of the Ultimaster Stent
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 204
- Registration Number
- NCT05677711
- Locations
- 🇰🇷
Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 37
- Registration Number
- NCT05665023
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 108
- Registration Number
- NCT05661552
- Locations
- 🇰🇷
Yongcheol Kim, Yongin, Gyeonggi-do, Korea, Republic of
CREATE Trial, Prospective, Observational Study
Recruiting
- Conditions
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 300
- Registration Number
- NCT05658250
- Locations
- 🇰🇷
Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of
Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 260
- Registration Number
- NCT05656118
- Locations
- 🇰🇷
Yongcheol Kim, Yongin, Gyeonggi-do, Korea, Republic of
Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
Recruiting
- Conditions
- First Posted Date
- 2022-12-07
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 54
- Registration Number
- NCT05640024
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Relative Importance of Cardiovascular Risk Factors and Echocardiographic Parameters Affecting Left Atrial Strain
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 2500
- Registration Number
- NCT05638230
- Locations
- 🇰🇷
Minkwan Kim, Yongin, Gyeonggi, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath